BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC)

Share this content:

BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC)

Sponsor and Collaborators     
Memorial Sloan-Kettering Cancer Center
Novartis

Contact    
Ana Molina, MD     646-422-4313     
Robert Motzer, MD     646-422-4312         

Investigator
Ana Molina, MD     
Memorial Sloan-Kettering Cancer Center

ClinicalTrials.gov Identifier
NCT01453595

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs